Digitisation | June 22, 2022
Iktos and Zealand Pharma to develop AI technology for peptide drug design
Agreement to co-develop artificial intelligence (AI) technology for the application in peptide drug design
Agreement to co-develop artificial intelligence (AI) technology for the application in peptide drug design
Bioresource Technology's state of the art manufacturing facility in Weston, Florida
This investment will facilitate a Cipla entity's strategic participation in the Poe diagnostics and AMR space through the design, development, and manufacturing of microfluidics-based technologies
Ganguly will execute company's strategic focus on leveraging CustomGlycan to develop novel therapeutics
TMA will leverage Syntegra's synthetic data engine to accelerate the building of predictive diagnostic algorithms
QIAGEN has started its cloud transformation journey with the firm belief that cloud computing can be a key enabler of future business growth
Becomes the first airline globally to develop and launch sustainable, temperature-controlled containers for the transportation of pharmaceuticals
New Director supports NASDAQ rule on diversity
During the research term, Olema will contribute funding to Aurigene to facilitate ongoing discovery efforts.
Bayer now present in four of the largest biotechnology hubs in the United States
Subscribe To Our Newsletter & Stay Updated
